Year: 2016
Type: review
Abstract: In mammals, cyclic adenosine monophosphate (cAMP) is an intracellular second messenger that is usually elicited by binding of hormones and neurotransmitters to G protein-coupled receptors (GPCRs). cAMP exerts many of its physiological effects by activating cAMP-dependent protein kinase (PKA), which in turn phosphorylates and regulates the functions of downstream protein targets including ion channels, enzymes, and transcription factors. cAMP/PKA signaling pathway regulates glucose homeostasis at multiple levels including insulin and glucagon secretion, glucose uptake, glycogen synthesis and breakdown, gluconeogenesis, and neural control of glucose homeostasis. This review summarizes recent genetic and pharmacological studies concerning the regulation of glucose homeostasis by cAMP/PKA in pancreas, liver, skeletal muscle, adipose tissues, and brain. We also discuss the strategies for targeting cAMP/PKA pathway for research and potential therapeutic treatment of type 2 diabetes mellitus (T2D).
DOI: 10.1530/jme-15-0316
Authors: Haihua Yang, Linghai Yang
Institutions: Zhengzhou Children's Hospital, University of Washington
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: cAMP/PKA signaling, cyclic AMP, protein kinase A, type 2 diabetes, glycemic control, glucose homeostasis, G protein-coupled receptors, insulin secretion, glucagon secretion, glucose uptake, gluconeogenesis, glycogen metabolism, pancreatic beta cells, liver, skeletal muscle, adipose tissue, brain, therapeutic target
Open Access status: bronze
OpenAlex ID: W2408117442
